MT 500
Latest Information Update: 06 Jun 2002
At a glance
- Originator Roche
- Class
- Mechanism of Action Serotonin 2B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Migraine
Most Recent Events
- 06 Jun 2002 Discontinued - Phase-I for Migraine in USA (unspecified route)
- 23 May 2000 New profile
- 23 May 2000 Phase-I clinical trials for Migraine in USA (Unknown route)